Mylan's Bresch on New FDA Rules, Company Outlook

Your next video will start in

Recommended Videos

  • Info

  • Comments

Oct. 27 (Bloomberg) -- Heather Bresch, president of Mylan Inc., discusses drug industry regulation and the outlook for the company's sales. Generic-drug makers such as Mylan will have to meet tighter standards to prove their blood-thinners and anti-seizure treatments work as well brand-name products, the U.S. Food and Drug Administration said earlier this week. Bresch, who will assume the chief executive officer post on Jan. 1, speaks on Bloomberg Television's "InBusiness With Margaret Brennan." (Source: Bloomberg)


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change